RBR-8w27x5已完成未知
Role of the Fifroblastic growth factor 23 (FGF2) in the Bone Disease in Idiopathic Hypercalciuria
Faculdade de Medicina da Universidade Federal de Minas Gerais0 个研究点开始时间: 2017年12月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 3Y 至 21Y（—）
入选标准
- •Pediatric patients; both genders; with diagnosis of Idiopathic Hypercalciuria; age between 3 and 21 years; with diurnal and nocturnal urinary sphincter control.
排除标准
- •Pregnant adolescents; patients with nephrocalcinosis; chronic immobilization; hypercalcemia; history of malignancy; excessive intake of calcium and vitamin D; hyperuricemia; prolonged corticoterapia; renal tubular diseases; use of drugs that interfere with calcium metabolism.
研究者
相似试验
招募中
不适用
Association of fibroblast growth factor 23 (FGF23) with urate metabolism in patients with chronic kidney disease (CKD): a cross-sectional study.Chronic kidney diseaseJPRN-UMIN000020652ational Hospital Organization Kyushu Medical Center99,999
已完成
不适用
Physiologic Regulation of FGF-23HypoparathyroidismNCT00356512National Institute of Dental and Craniofacial Research (NIDCR)20
招募中
不适用
The investigation of FGF23, a prognostic factor in children with chronic kidney disease and bone metabolismChronic kidney diseaseJPRN-UMIN000028891Osaka Women's and Children's Hospital200
已完成
不适用
FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney DiseaseSecondary HyperparathyroidismNCT00999037University of California, Los Angeles18
尚未招募
不适用
Fibroblast Growth Factor 23 in Chronic Respiratory FailureChronic Respiratory FailureNCT05258370Assistance Publique - Hôpitaux de Paris50